Eisner Mark's Form 4 filing
Kyntra Bio, Inc. (KYNB) · filed Mar 10, 2023
- Accession no.
- 0001209191-23-018063
- Filed
- Mar 10, 2023
- Trade date
- Mar 8-10, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $360.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Eisner MarkCIK 0001834161 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2023 | Common Stock | SSaleDisposed | −7,363 | $21.16 | −$155,801.08 | 165,133 | Direct | |
| Mar 8, 2023 | Common Stock | AGrant or awardAcquired | +7,732 | $0.00 | $0 | 172,865 | Direct | |
| Mar 8, 2023 | Common Stock | AGrant or awardAcquired | +12,451 | $0.00 | $0 | 185,316 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −3,885 | $20.20 | −$78,477 | 181,431 | Direct | |
| Mar 10, 2023 | Common Stock | SSaleDisposed | −6,255 | $20.20 | −$126,351 | 175,176 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.